The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults ; day:15 ; month:3 ; year:2019 ; pages:1-8
European journal of clinical pharmacology ; (15.3.2019), 1-8
- Urheber
-
Bury, Didi
ter Heine, Rob
Garde, Ewoudt M. W. van de
Nijziel, Marten R.
Grouls, Rene J.
Deenen, Maarten J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-019-02657-6
- URN
-
urn:nbn:de:101:1-2019040722401503558144
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bury, Didi
- ter Heine, Rob
- Garde, Ewoudt M. W. van de
- Nijziel, Marten R.
- Grouls, Rene J.
- Deenen, Maarten J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
Target site pharmacokinetics of antiinfectives in the treatment of serious gram positive infections : linezolid and vancomycin
Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
Impact of linker modification and PEGylation of vancomycin conjugates on structure-activity relationships and pharmacokinetics
Natural history of chronic idiopathic neutropenia of the adult
Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia
Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
Target site pharmacokinetics of antiinfectives in the treatment of serious gram positive infections : linezolid and vancomycin
Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
Impact of linker modification and PEGylation of vancomycin conjugates on structure-activity relationships and pharmacokinetics
Natural history of chronic idiopathic neutropenia of the adult
Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia
Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
Target site pharmacokinetics of antiinfectives in the treatment of serious gram positive infections : linezolid and vancomycin
Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
Impact of linker modification and PEGylation of vancomycin conjugates on structure-activity relationships and pharmacokinetics
Natural history of chronic idiopathic neutropenia of the adult
Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study